S. Xie

Judith A. Long, Amy Y Tsou, Sharon X Xie, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.

J. Trojanowski, M. Grossman, V. Lee, 2012, Brain : a journal of neurology.

The Penn ADCC: Integrating Neurodegenerative Disease Research Across Disciplines, Conditions, and Population Groups

J. Trojanowski, J. Karlawish, S. Arnold, 2015 .

Prenatal healthcare providers’ Gaucher disease carrier screening practices

S. Xie, V. Deerlin, E. Wood, 2012, Genetics in Medicine.

The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.

M. Grossman, S. Ash, Jessica O'Shea, 2012, Neuropsychology.

Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.

J. Gee, J. Trojanowski, J. Phillips, 2019, Brain : a journal of neurology.

Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration

J. Trojanowski, M. Grossman, C. McMillan, 2019, Front. Neurosci..

A memory and organizational aid improves AD research consent capacity: Results of a randomized, controlled trial

J. Karlawish, R. Gur, S. Xie, 2010 .

Through Thick and Thin: Baseline Cortical Volume and Thickness Predict Performance and Response to Transcranial Direct Current Stimulation in Primary Progressive Aphasia

Denise Y. Harvey, Nicole R Nissim, J. Phillips, 2022, Frontiers in Human Neuroscience.

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

J. Farrar, R. Gross, A. DeMichele, 2013, BMC Cancer.

Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline

L. Shaw, P. Yushkevich, Sandhitsu R. Das, 2022, Journal of Alzheimer's disease reports.

Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.

M. Grossman, D. Irwin, S. Xie, 2013, JAMA neurology.

Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer’s disease

J. Trojanowski, J. Phillips, M. Grossman, 2022, Acta Neuropathologica.

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study

D. Jennings, A. Siderowf, K. Marek, 2017, Movement disorders : official journal of the Movement Disorder Society.

Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.

J. Trojanowski, V. Lee, S. Xie, 2008, Archives of neurology.

Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease

C. Clark, F. Johnson, S. Xie, 2009, Alzheimer's & Dementia.

A comparison of multiple urine markers for interstitial cystitis.

S. Xie, L. Demers, R. Hurst, 2002, The Journal of urology.

APOE, thought disorder, and SPARE‐AD predict cognitive decline in established Parkinson's disease

Christos Davatzikos, Jimit Doshi, Daniel Weintraub, 2018, Movement disorders : official journal of the Movement Disorder Society.

Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam

J. Trojanowski, D. Perl, D. Galasko, 2007, Acta Neuropathologica.

Uncovering the expectancy effect: the validation of the acupuncture expectancy scale.

S. Xie, J. Mao, M. Bowman, 2010, Alternative therapies in health and medicine.

Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors

J. Farrar, A. DeMichele, S. Xie, 2009, Integrative cancer therapies.

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Christos Davatzikos, Murray Grossman, Mary Naylor, 2010, Alzheimer's & Dementia.

Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer’s disease

J. Trojanowski, J. Phillips, M. Grossman, 2022, Acta Neuropathologica.

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia

J. Trojanowski, C. Davatzikos, L. Shaw, 2016, PloS one.

Plasma phosphorylated tau181 predicts cognitive and functional decline

J. Trojanowski, M. Grossman, L. Shaw, 2022, Annals of clinical and translational neurology.

The Dementia Severity Rating Scale Predicts Clinical Dementia Rating Sum of Boxes Scores

C. Clark, S. Arnold, S. Xie, 2014, Alzheimer disease and associated disorders.

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

J. Farrar, R. Gross, A. DeMichele, 2013, BMC Cancer.

Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.

R. Postuma, T. Simuni, B. Tran, 2016, Parkinsonism & related disorders.

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

J. Trojanowski, A. Siderowf, K. Marek, 2016, Annals of clinical and translational neurology.

Plasma biomarkers of depressive symptoms in older adults

D. Bennett, J. Trojanowski, L. Shaw, 2012, Translational Psychiatry.

Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial.

A. Beck, T. Ten Have, Gregory K Brown, 2005, JAMA.

Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease

Murray Grossman, Katya Rascovsky, Sharon X Xie, 2013, Alzheimer disease and associated disorders.

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

J. Trojanowski, C. Clark, L. Shaw, 2010, Annals of neurology.

Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.

John L. Robinson, J. Trojanowski, M. Grossman, 2019, Journal of neuropathology and experimental neurology.

Non-Alzheimer’s contributions to dementia and cognitive resilience in The 90+ Study

John L. Robinson, J. Trojanowski, V. Lee, 2018, Acta Neuropathologica.

Distribution patterns of tau pathology in progressive supranuclear palsy

John L. Robinson, J. Trojanowski, M. Grossman, 2020, Acta Neuropathologica.

The development and convergence of co-pathologies in Alzheimer's disease.

John L. Robinson, Jeffrey J. Nirschl, J. Trojanowski, 2020, Brain : a journal of neurology.

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

C. Jack, C. DeCarli, M. Weiner, 2011, Acta Neuropathologica.

Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease

J. Trojanowski, D. Weintraub, S. Xie, 2022, medRxiv.

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

J. Trojanowski, M. Grossman, L. Shaw, 2021, Movement disorders : official journal of the Movement Disorder Society.

Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.

J. Amsterdam, S. Xie, J. Mao, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

T. Montine, J. Trojanowski, D. Jennings, 2013, Annals of neurology.

Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.

D. Margolis, J. Metlay, S. Xie, 2012, Archives of dermatology.

Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.

J. Amsterdam, S. Xie, J. Mao, 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial.

J. Amsterdam, S. Xie, J. Mao, 2014, Journal of clinical trials.

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study

J. Detre, S. Arnold, D. Wolk, 2017, Alzheimer disease and associated disorders.

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

J. Trojanowski, M. Grossman, V. Lee, 2011, Acta Neuropathologica.

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

John L. Robinson, J. Trojanowski, M. Grossman, 2018, Brain : a journal of neurology.

Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale

Daniel Weintraub, Andrew Siderowf, Sharon X Xie, 2012, Movement disorders : official journal of the Movement Disorder Society.

Adjustment for measurement error in evaluating diagnostic biomarkers by using an internal reliability sample

Matthew T. White, Matthew T White, Sharon X Xie, 2013, Statistics in medicine.

Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging

David R. Roalf, David A. Wolk, Steven E. Arnold, 2013, Alzheimer's & Dementia.

How Does an Alzheimer’s Disease Patient’s Role in Medical Decision Making Change Over Time?

J. Karlawish, S. Xie, K. Hirschman, 2004, Journal of geriatric psychiatry and neurology.

Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial.

J. Farrar, A. DeMichele, S. Xie, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility trial of electro-acupuncture for aromatase inhibitor related arthralgia in breast cancer survivors.

J. Farrar, A. DeMichele, S. Xie, 2009 .

Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors

J. Farrar, A. DeMichele, S. Xie, 2009, Cancer.

Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients

S. Xie, A. Chen-Plotkin, L. Chahine, 2015, Movement disorders : official journal of the Movement Disorder Society.

CSF Apo-E levels associate with cognitive decline and MRI changes

M. Weiner, J. Trojanowski, C. Davatzikos, 2014, Acta Neuropathologica.

Plasma Apolipoprotein A 1 as a Biomarker for Parkinson ' s Disease

Ken, Marek, J. Trojanowski, 2013 .

Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain

John L. Robinson, J. Trojanowski, V. Lee, 2018, Acta Neuropathologica Communications.

Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

John L. Robinson, J. Trojanowski, M. Grossman, 2009, Archives of neurology.

Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis

F. Johnson, S. Xie, R. Pignolo, 2014, Disease Models & Mechanisms.

The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice

J. Trojanowski, V. Lee, S. Xie, 2012, The Journal of Neuroscience.

Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

J. Trojanowski, V. Lee, S. Xie, 2010, The Journal of Neuroscience.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Development of and psychometric testing for the Brief Pain Inventory–Facial in patients with facial pain syndromes

John Y. K. Lee, J. Farrar, S. Xie, 2010 .

Tau deposition patterns are associated with functional connectivity in primary tauopathies

J. Trojanowski, M. Grossman, J. Seibyl, 2022, Nature Communications.

Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity

S. Xie, K. Luk, A. Caputo, 2018, Acta Neuropathologica.

Course of psychiatric symptoms and global cognition in early Parkinson disease

Kara M. Smith, D. Weintraub, S. Xie, 2014, Neurology.

Research consent capacity varies with executive function and memory in Parkinson's disease

J. Karlawish, D. Weintraub, S. Xie, 2016, Movement disorders : official journal of the Movement Disorder Society.

Cognitive impairment and PD patients' capacity to consent to research

J. Karlawish, A. Siderowf, D. Weintraub, 2013, Neurology.

A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.

J. Karlawish, R. Gur, S. Xie, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment

J. Karlawish, S. Xie, B. James, 2005, Neurology.

Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease

S. Xie, S. Mantri, T. Tropea, 2021, Movement disorders clinical practice.

Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases

Matthew T. White, John L. Robinson, J. Trojanowski, 2011, Acta Neuropathologica.

Epilepsy in families: Age at onset is a familial trait, independent of syndrome

M. Epstein, S. Berkovic, S. Xie, 2019, Annals of neurology.

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

William T. Hu, J. Trojanowski, H. Soares, 2011, Annals of neurology.

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.

S. Xie, D. Lipson, R. Kotloff, 2006, American journal of respiratory and critical care medicine.

Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration

A Chatterjee, J Q Trojanowski, X Wang, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia

J. Trojanowski, M. Grossman, A. Siderowf, 2019, Annals of neurology.

Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo‐controlled study

D. Weintraub, E. Mamikonyan, S. Xie, 2015, Movement disorders : official journal of the Movement Disorder Society.

A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.

J. Farrar, A. DeMichele, S. Xie, 2014, European journal of cancer.

Expectancy in real and sham electroacupuncture: does believing make it so?

J. Farrar, A. DeMichele, S. Xie, 2014, Journal of the National Cancer Institute. Monographs.

Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

Chi Li, Bin Zhang, John Q Trojanowski, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders

J. Trojanowski, M. Grossman, V. Lee, 2018, Annals of neurology.

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

T. Montine, J. Trojanowski, G. Jicha, 2017, The Lancet Neurology.

Quality, and not Just Quantity, of Education Accounts for Differences in Psychometric Performance between African Americans and White Non-Hispanics with Alzheimer's Disease

S. Arnold, R. Hamilton, S. Xie, 2012, Journal of the International Neuropsychological Society.

Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.

Christos Davatzikos, Jimit Doshi, Michel Bilello, 2015, Journal of Alzheimer's disease : JAD.

Genetic Testing and Parkinson Disease: Assessment of Patient Knowledge, Attitudes, and Interest

A. Siderowf, S. Xie, V. Deerlin, 2011, Journal of Genetic Counseling.

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

David A Wolk, John Q Trojanowski, Jon B Toledo, 2012, Brain : a journal of neurology.

Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.

D. Weintraub, S. Xie, N. Dahodwala, 2019, Parkinsonism & related disorders.

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

John L. Robinson, J. Trojanowski, M. Grossman, 2017, Acta neuropathologica communications.

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.

J. Trojanowski, J. Karlawish, A. Siderowf, 2016, Parkinsonism & related disorders.

Statins and Cognition in Parkinson's Disease.

J. Trojanowski, D. Weintraub, S. Xie, 2017, Journal of Parkinson's disease.

Genetic predictors of survival in behavioral variant frontotemporal degeneration

J. Trojanowski, M. Grossman, V. Lee, 2019, Neurology.

Symptom Burden Among Cancer Survivors: Impact of Age and Comorbidity

J. Farrar, S. Xie, K. Armstrong, 2007, The Journal of the American Board of Family Medicine.

Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.

J. Farrar, S. Xie, K. Armstrong, 2007, Complementary therapies in medicine.

Signature laminar distributions of pathology in frontotemporal lobar degeneration

J. Trojanowski, M. Grossman, C. McMillan, 2022, Acta Neuropathologica.

Patterns of neuropsychological impairment in frontotemporal dementia

Katy A. Cross, M. Grossman, P. Moore, 2007, Neurology.

Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample

Jarcy Zee, Sharon X Xie, S. Xie, 2015, Biometrics.

Assessing treatment effects with surrogate survival outcomes using an internal validation subsample

S. Xie, J. Zee, 2015, Clinical trials.

Online Exclusive Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology

J. Trojanowski, C. Davatzikos, L. Shaw, 2013 .

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Charles DeCarli, Douglas Galasko, Joseph Quinn, 2003, Archives of neurology.

The heterogeneity of mild cognitive impairment: A neuropsychological analysis

Tania Giovannetti, Melissa Lamar, Catherine C Price, 2009, Journal of the International Neuropsychological Society.

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

Leslie M. Shaw, John Q. Trojanowski, Sharon X. Xie, 2013, Acta Neuropathologica.

Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease

John L. Robinson, J. Trojanowski, V. Lee, 2021, Acta Neuropathologica.

Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.

John L. Robinson, J. Trojanowski, G. Jicha, 2020, Brain : a journal of neurology.

Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases

John L. Robinson, J. Trojanowski, M. Grossman, 2017, Journal of neuropathology and experimental neurology.

Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.

John L. Robinson, J. Trojanowski, P. Moberg, 2010, Archives of neurology.

Physical activity and telomere length in early stage breast cancer survivors

R. Speck, A. DeMichele, S. Xie, 2014, Breast Cancer Research.

Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors

S. Xie, Katie Herbst-Robinson, Michael J. James, 2015, Scientific Reports.

The Kaplan–Meier method for estimating and comparing proportions in a randomized controlled trial with dropouts

S. Xie, J. Zee, 2018, Biostatistics & epidemiology.

Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression.

J. Amsterdam, S. Xie, J. Mao, 2019, Journal of alternative and complementary medicine.

Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial.

P. Kantoff, F. Barg, P. Gehrman, 2019, Journal of the National Cancer Institute.

Cox regression model with doubly truncated data

S. Xie, L. Rennert, 2018, Biometrics.

Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods

D. Wolk, R. Hamilton, T. Giovannetti, 2021, Journal of Alzheimer's Disease.

Attempts : A Randomized Controlled Trial Cognitive Therapy for the Prevention of Suicide

A. Beck, Gregory K Brown, J. Hollander, 2005 .

Longitudinal study of normal cognition in Parkinson disease

J. Trojanowski, A. Siderowf, D. Weintraub, 2015, Neurology.

Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them?

J. Karlawish, S. Xie, B. James, 2005, The Gerontologist.

Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication?

J. Karlawish, S. Xie, B. James, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases

J. Trojanowski, V. Lee, S. Arnold, 2013, The Journal of comparative neurology.

Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease

Daniel Weintraub, Sharon X Xie, Kara M. Smith, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.

Irving E. Vega, J. Karlawish, C. Clark, 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology

J. Trojanowski, M. Grossman, C. McMillan, 2021, Acta neuropathologica communications.

Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer’s disease

H. Coslett, A. Chatterjee, M. Grossman, 2009, Journal of the International Neuropsychological Society.

Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia.

Irving E. Vega, J. Trojanowski, J. Karlawish, 2013, Journal of Alzheimer's disease : JAD.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

L. Beckett, H. Snyder, A. Brickman, 2019, Alzheimer's & dementia.

Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

J. Trojanowski, A. Siderowf, D. Weintraub, 2020, Movement disorders : official journal of the Movement Disorder Society.

Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease

William T. Hu, J. Trojanowski, H. Soares, 2013, Journal of the Neurological Sciences.

Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration

M. Grossman, C. McMillan, D. Irwin, 2015, Neurology.

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

William T. Hu, A. Fagan, D. Holtzman, 2015, Alzheimer's & dementia.

Older Adult Normative Data for the Sniffin’ Sticks Odor Identification Test

P. Moberg, D. Roalf, D. Wolk, 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau

D. Wolk, L. Wisse, S. Xie, 2021, NeuroImage: Clinical.

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease

R. Doty, A. Siderowf, M. Stern, 2010, Movement disorders : official journal of the Movement Disorder Society.

Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients

S. Palmer, S. Xie, K. Armstrong, 2012, Evidence-based complementary and alternative medicine : eCAM.

The Philadelphia Brief Assessment of Cognition (PBAC): A Validated Screening Measure for Dementia

Murray Grossman, Katya Rascovsky, Matthew T. White, 2011, The Clinical neuropsychologist.

Genetic influences on cognitive decline in Parkinson's disease

A. Siderowf, M. Stern, D. Weintraub, 2012, Movement disorders : official journal of the Movement Disorder Society.

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration

X. Wang, J. Trojanowski, H. Coslett, 2008, Neurology.

Occupational attainment influences longitudinal decline in behavioral variant frontotemporal degeneration

M. Grossman, C. McMillan, D. Irwin, 2019, Brain Imaging and Behavior.

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype

T. Montine, J. Trojanowski, J. Quinn, 2016, Annals of clinical and translational neurology.

The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease

B. Devlin, G. Schellenberg, J. Trojanowski, 2013, Acta neuropathologica communications.

Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis.

Murray Grossman, Anjan Chatterjee, Peachie Moore, 2009, Neuropsychology.

Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010–2018

S. Kasner, S. Xie, S. Hennessy, 2020, Epilepsy & Behavior.

Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy

J. Trojanowski, V. Lee, S. Xie, 2011, Acta Neuropathologica.

Cox regression model under dependent truncation

Sharon X. Xie, Lior Rennert, S. Xie, 2018, Biometrics.

Plasma Phosphorylated Tau181 is a Biomarker of Alzheimer's Disease Pathology and Associated with Cognitive and Functional Decline

J. Trojanowski, M. Grossman, L. Shaw, 2022, SSRN Electronic Journal.

Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration

J. Trojanowski, M. Grossman, L. Shaw, 2017, Annals of neurology.

Building an integrated neurodegenerative disease database at an academic health center

Murray Grossman, John Q. Trojanowski, Steven E. Arnold, 2011, Alzheimer's & Dementia.

Naltrexone for impulse control disorders in Parkinson disease

A. Siderowf, M. Stern, D. Weintraub, 2014, Neurology.

Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15‐item Geriatric Depression Scale (GDS‐15)

J. Karlawish, A. Siderowf, D. Weintraub, 2007, International Journal of Geriatric Psychiatry.

Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer℉s disease.” Biochemical biomarkers of late-life dementia

J. Trojanowski, C. Clark, V. Lee, 2006, Alzheimer's & Dementia.

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia

J. Trojanowski, A. Siderowf, D. Weintraub, 2017, PloS one.

Association between cognition and function in patients with Parkinson disease with and without dementia

J. Karlawish, A. Siderowf, D. Weintraub, 2010, Movement disorders : official journal of the Movement Disorder Society.

Rate of Decline in Alzheimer Disease Measured by a Dementia Severity Rating Scale

J. Karlawish, C. Clark, S. Arnold, 2009, Alzheimer disease and associated disorders.

Amyloid‐Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia

J. Trojanowski, M. Pontecorvo, A. Siderowf, 2016, Movement disorders clinical practice.

Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.

S. Xie, N. Vapiwala, J. Mao, 2013, International journal of radiation oncology, biology, physics.

Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

J. Trojanowski, A. Siderowf, P. Martínez-Martín, 2020, Journal of Parkinson's disease.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

J. Trojanowski, P. Moberg, B. Tran, 2017, Journal of Parkinson's disease.

Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial

S. Xie, J. Mao, S. Garland, 2017, Menopause.

CHoosing Options for Insomnia in Cancer Effectively (CHOICE): Design of a patient centered comparative effectiveness trial of acupuncture and cognitive behavior therapy for insomnia.

F. Barg, P. Gehrman, S. Xie, 2016, Contemporary clinical trials.

Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease.

Kara M. Smith, M. Grossman, S. Ash, 2018, Journal of speech, language, and hearing research : JSLHR.

Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

John L. Robinson, J. Trojanowski, V. Lee, 2023, Brain : a journal of neurology.

Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus

J. Trojanowski, L. Shaw, C. Clark, 2012, Fluids and Barriers of the CNS.

Cerebrovascular disease lesions are additive and tied to vascular risk factors and cognitive impairment.

John L. Robinson, J. Trojanowski, V. Lee, 2022, Free neuropathology.

Linked Patient and Provider Impressions of Outpatient Teleneurology Encounters

A. Siderowf, L. Wechsler, S. Xie, 2022, medRxiv.

Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study

B. Tran, D. Weintraub, E. Mamikonyan, 2023, Research Square.

Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants

J. Trojanowski, A. Siderowf, D. Weintraub, 2019, Movement disorders clinical practice.

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

J. Trojanowski, J. Karlawish, A. Siderowf, 2016, Movement disorders : official journal of the Movement Disorder Society.

Olfactory impairment predicts cognitive decline in early Parkinson's disease.

J. Toledo, B. Tran, D. Weintraub, 2016, Parkinsonism & related disorders.

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

A. Siderowf, M. Stern, D. Weintraub, 2014, Neurology.

Turning apathy into action in neurodegenerative disease: Development and pilot testing of a goal-directed behaviour app.

K. Rascovsky, S. Xie, D. Mechanic-Hamilton, 2023, Neuropsychological rehabilitation.

Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.

J. Amsterdam, S. Xie, J. Mao, 2014, Journal of clinical trials.

A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy

S. Xie, N. Vapiwala, J. Mao, 2012, Journal of palliative care & medicine.

Cognitive Therapy and Preventing Suicide Attempts—Reply

A. Beck, Gregory K Brown, J. Hollander, 2005 .

CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

J. Trojanowski, C. Clark, A. Siderowf, 2010, Neurology.

Tau spreading is driven by neuronal connectivity in primary tauopathies - evidence from tau-PET and histopathology

John L. Robinson, J. Trojanowski, M. Grossman, 2021, medRxiv.

Genetic and Neurophysiological Biomarkers of Neuroplasticity Inform Post-Stroke Language Recovery

Haley C. Dresang, Denise Y. Harvey, R. Hamilton, 2021, medRxiv.

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

J. Trojanowski, S. Arnold, W. Kukull, 2013, Brain : a journal of neurology.

Bias induced by ignoring double truncation inherent in autopsy‐confirmed survival studies of neurodegenerative diseases

S. Xie, L. Rennert, 2019, Statistics in medicine.

How do patients with Alzheimer disease rate their overall quality of life?

Sharon X Xie, J. Karlawish, S. Xie, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Expectancy in real and sham electroacupuncture: does believing make it so?

J. Farrar, A. DeMichele, S. Xie, 2014, Journal of the National Cancer Institute. Monographs.

Development of and psychometric testing for the Brief Pain Inventory-Facial in patients with facial pain syndromes.

S. Xie, H. I. Chen, Christopher Urban, 2010, Journal of neurosurgery.

Rate of Decline in Alzheimer Disease Measured by a Dementia Severity Rating Scale

J. Karlawish, C. Clark, S. Arnold, 2009, Alzheimer disease and associated disorders.

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

John L. Robinson, J. Trojanowski, V. Lee, 2017, Acta Neuropathologica Communications.

The heterogeneity of mild cognitive impairment: A neuropsychological analysis

M. Lamar, T. Giovannetti, D. Libon, 2009, Journal of the International Neuropsychological Society.

Research consent capacity varies with executive function and memory in Parkinson's disease

J. Karlawish, D. Weintraub, S. Xie, 2016, Movement disorders : official journal of the Movement Disorder Society.

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

A. Siderowf, M. Stern, D. Weintraub, 2009, Neurology.

Adjustment for measurement error in evaluating diagnostic biomarkers by using an internal reliability sample

Matthew T. White, S. Xie, 2013, Statistics in medicine.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

J. Trojanowski, P. Moberg, B. Tran, 2017, Journal of Parkinson's disease.

Common genetic variation is associated with longitudinal decline and network features in behavioral variant frontotemporal degeneration

D. Irwin, S. Xie, C. Olm, 2021, Neurobiology of Aging.